Description: Zelda Therapeutics is an Australian-based bio-pharmaceutical company that has secured exclusive, global access to an extensive set of human data related to medicinal cannabis based formulations and treatment protocols.
Home Page: www.zeliratx.com
101 St George's Terrace
Perth,
WA
6000
Australia
Phone:
61 8 6558 0886
Officers
| Name | Title |
|---|---|
| Mr. Osagie O. Imasogie Esq. | Founder & Chairman |
| Dr. Oludare Odumosu | MD, Global CEO & Director |
| Mr. Timothy Ryan Slate | Non-Exec. Director & Company Sec. |
| Mr. Rahul Ganesan | VP of Fin. & Accounting |
| Mr. Greg Blake | VP of Global and Head of Commercial & Partnering |
| Dr. Patty Washer | Clinical Trial Consultant |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.2891 |
| Price-to-Sales TTM: | 4.3704 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |